Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listMETHYL 2,5-DIHYDROXYCINNAMATE

METHYL 2,5-DIHYDROXYCINNAMATE

METHYL 2,5-DIHYDROXYCINNAMATE Structural

What is METHYL 2,5-DIHYDROXYCINNAMATE?

Chemical properties

Yellow-Brown Crystalline Powder

The Uses of METHYL 2,5-DIHYDROXYCINNAMATE

A stable Erbstatin analogue that inhibits tyrosine kinase. Shown to delay the S-phase induction by epidermal growth factor in quiescent normal rat kidney cells, without affecting the total amount of DNA synthesis

The Uses of METHYL 2,5-DIHYDROXYCINNAMATE

An inhibitor of the EGF receptor associated tyrosine kinase

What are the applications of Application

Erbstatin Analog is a stable inhibitor of EGFR tyrosine kinase

Definition

ChEBI: 2,5-dihydroxycinnamic acid methyl ester is a cinnamate ester that is the methyl ester of 2,5-dihydroxycinnamic acid. It has a role as a human urinary metabolite, a plant metabolite, a geroprotector and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a cinnamate ester, a member of hydroquinones and a methyl ester.

Properties of METHYL 2,5-DIHYDROXYCINNAMATE

Melting point: 178-180°C
Density  1.318±0.06 g/cm3 (20 ºC 760 Torr)
storage temp.  Keep in dark place,Sealed in dry,Room Temperature
solubility  0.1 M NaOH: soluble
form  crystalline
color  yellow
Water Solubility  Soluble in methanol or 0.1M NaOH. Insoluble in water
CAS DataBase Reference 63177-57-1(CAS DataBase Reference)

Safety information for METHYL 2,5-DIHYDROXYCINNAMATE

Signal word Warning
Pictogram(s)
ghs
Skull and Crossbones
Acute Toxicity
GHS06
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H301:Acute toxicity,oral
H311:Acute toxicity,dermal
H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
H331:Acute toxicity,inhalation
H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P264:Wash hands thoroughly after handling.
P264:Wash skin thouroughly after handling.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P405:Store locked up.

Computed Descriptors for METHYL 2,5-DIHYDROXYCINNAMATE

Related products of tetrahydrofuran

You may like

  • Methyl 2,5-dihydroxycinnamate 95% CAS 63177-57-1
    Methyl 2,5-dihydroxycinnamate 95% CAS 63177-57-1
    63177-57-1
    View Details
  • Methyl 2,5-Dihydroxycinnamate CAS 63177-57-1
    Methyl 2,5-Dihydroxycinnamate CAS 63177-57-1
    63177-57-1
    View Details
  • (R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonate
    (R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonate
    2416850-45-6
    View Details
  • methyl 3-fluoro-4- thiomorpholino phenylcarbamate
    methyl 3-fluoro-4- thiomorpholino phenylcarbamate
    2760359-22-4
    View Details
  • 4,6-dichloro-2-propylthiopyrimidine-5-amine 145783-15-9 98%
    4,6-dichloro-2-propylthiopyrimidine-5-amine 145783-15-9 98%
    145783-15-9
    View Details
  • 151767-02-1 Montelukast Sodium IP/USP 98%
    151767-02-1 Montelukast Sodium IP/USP 98%
    151767-02-1
    View Details
  • Valacyclovir Hydrochloride IH 98%
    Valacyclovir Hydrochloride IH 98%
    124832-27-5
    View Details
  • 2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol 98%
    2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol 98%
    142569-70-8
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.